A. Oku

发表

Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase.

J. Nezu, A. Oku, M. Jones, 1997, Genomics.

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

J. Nezu, A. Oku, M. Shimane, 2000, Biochemical and biophysical research communications.

GENETIC POLYMORPHISM OF DRUG TRANSPORTERS

J. Nezu, A. Oku, M. Shimane, 2000 .

Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1

J. Nezu, A. Oku, M. Shimane, 1997, FEBS letters.

Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency

E. Mayatepek, J. Nezu, A. Oku, 2000, Human mutation.

Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.

J. Nezu, A. Oku, M. Shimane, 2001, Molecular pharmacology.

Molecular and Physiological Evidence for Multifunctionality of Carnitine / Organic Cation Transporter OCTN 2

J. Nezu, A. Oku, M. Shimane, 2001 .

Loss of wild‐type carrier‐mediated L‐carnitine transport activity in hepatocytes of juvenile visceral steatosis mice

K. Miyamoto, J. Nezu, A. Oku, 1999, Hepatology.

Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice*

J. Nezu, A. Oku, M. Shimane, 2000, The Journal of Biological Chemistry.

Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients.

J. Nezu, A. Oku, M. Shimane, 1999, Biochemical and biophysical research communications.

Advances in Brief No Evidence of Peutz-Jeghers Syndrome Gene LKB 1 Involvement in Left-sided Colorectal Carcinomas 1

L. Aaltonen, P. Laiho, J. Kim, 2000 .

Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.

J. Nezu, A. Oku, M. Shimane, 1999, The Journal of pharmacology and experimental therapeutics.

Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2*

J. Nezu, A. Oku, M. Shimane, 1998, The Journal of Biological Chemistry.

Molecular and Functional Characterization of Carnitine/Organic Cation Transporter OCTN Family in Human and Mouse.

J. Nezu, A. Oku, M. Shimane, 2000 .

No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas.

L. Aaltonen, P. Laiho, J. Mecklin, 2000, Cancer research.

Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity.

N. Guex, S. Antonarakis, C. Rossier, 1998, American journal of human genetics.

A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain*

M. Shibuya, Y. Yazaki, A. Oku, 1998, The Journal of Biological Chemistry.

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

G. Tsujimoto, T. Matsuishi, J. Nezu, 1999, Nature Genetics.

Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.

J. Nezu, A. Oku, M. Shimane, 1999, The Journal of pharmacology and experimental therapeutics.